meta_pixel
Tapesearch Logo
Log in
The World in Brief from The Economist

Britain vows to recognise Palestine unless Israel changes course, and more

The World in Brief from The Economist

The Economist

News, Global News, News & Politics, Daily News

4.11.2K Ratings

🗓️ 30 July 2025

⏱️ 5 minutes

🧾️ Download transcript

Summary

Sir Keir Starmer, Britain’s prime minister, said that the country would recognise a Palestinian state in September unless Israel agreed to a ceasefire and a two-state solution.

Transcript

Click on a timestamp to play from that location

0:00.0

Hello, you're listening to the free edition of the world in brief from The Economist.

0:11.2

As a reminder, if you subscribe to The Economist, you'll get access to a deeper look at the day ahead, updated three times a day.

0:20.1

If you're already an economist subscriber, visit

0:22.9

economist.com slash espresso or visit our espresso app to start listening. Here's today's

0:29.5

free edition.

0:35.3

This is the world in brief from The Economist.

0:41.7

Our top stories.

0:45.1

Sarkia Stama, Britain's Prime Minister, said that the country would recognise a Palestinian

0:50.2

state in September, unless Israel agreed to a ceasefire and a two-state solution.

0:57.3

Last week, Emmanuel Macron, France's president, promised to recognize Palestine.

1:02.9

Secere was at first reluctant to follow suit, but he has come under pressure to act.

1:07.8

Around 130 MPs from his own Labour party signed a letter last week

1:13.3

urging recognition. Benjamin Netanyahu, Israel's prime minister, said Sykia's ultimatum

1:20.0

rewards Hamas' monstrous terrorism. After two days of talks, officials from America and China agreed to extend an ongoing tariff

1:30.5

truce that is due to expire on August 12th.

1:34.4

However, Scott Besant, America's Treasury Secretary, said Donald Trump must approve the

1:40.0

continuation of the pause.

1:42.4

In May, America agreed to temporarily slash its reciprocal

1:46.0

tariff on China from 125% to 10%. China similarly cut retaliatory levies. Shares in Novo-Nordes

1:57.2

plunged after the Danish drug maker cut its full-year sales and profit forecasts for the

2:03.5

second time in 2025. It cited weaker than expected demand for We Govi and Ozenpick, its weight

2:11.2

loss drugs, amid intensifying competition. Once Europe's most valuable company, Novo Nordisk has lost more than half its market

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Economist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Economist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.